The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Kala Bio announced that it is ready to ship its first commercial AI product, which is expected to transform the company’s operations and potentially the biotech industry. The product is set to launch ...

Kala Bio (KALA) added ~14% in early premarket trading on Wednesday after the eye drug developer announced plans to license AI capabilities to the biopharma industry in a bid to become an AI ...

Ambarella (AMBA) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.1 per share. This compares to earnings of $0.11 per share a year ago. These figures are ...

Kala azar (visceral leishmaniasis), also called black fever, is on the cusp of elimination in India, with a decline in cases from 77102 in 1992 to 9241 in 2014, 524 cases in 2023 and finally, to only ...

KALA BIO, Inc. (NASDAQ: KALA) shares jumped 22.16% to $1.13 in after-hours trading on Wednesday. Check out the current price of KALA stock here. Securities and Exchange Commission filings indicate ...

Ambarella has successfully pivoted from automotive to IoT, driving 50% YoY revenue growth and higher ASPs with its CV5/CV7 SoCs. IoT now represents 75% of AMBA's revenue, offering faster monetization ...

Amba Kak has spent the last fifteen years designing and advocating for technology policy in the public interest, ranging from network neutrality to privacy to algorithmic accountability, across ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Kala Pharmaceuticals ...